Authors:
Haubrich, RH
Currier, JS
Forthal, DN
Beall, G
Kemper, CA
Johnson, D
Dube, MR
Hwang, J
Leedom, JM
Tilles, J
McCutchan, JA
Citation: Rh. Haubrich et al., A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy, CLIN INF D, 33(7), 2001, pp. 1060-1068
Citation: Dn. Forthal et al., Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4(+) lymphocyte count, AIDS RES H, 17(6), 2001, pp. 553-561
Authors:
Kemper, CA
Witt, MD
Keiser, PH
Dube, MP
Forthal, DN
Leibowitz, M
Smith, DS
Rigby, A
Hellmann, NS
Lie, YS
Leedom, J
Richman, D
McCutchan, JA
Haubrich, R
Citation: Ca. Kemper et al., Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors, AIDS, 15(5), 2001, pp. 609-615
Citation: Dn. Forthal et al., Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells, J VIROLOGY, 75(15), 2001, pp. 6953-6961
Authors:
Atabani, S
Landucci, G
Steward, MW
Whittle, H
Tilles, JG
Forthal, DN
Citation: S. Atabani et al., Sex-associated differences in the antibody-dependent cellular cytotoxicityantibody response to measles vaccines, CL DIAG LAB, 7(1), 2000, pp. 111-113
Authors:
Haubrich, RH
Little, SJ
Currier, JS
Forthal, DN
Kemper, CA
Beall, GN
Johnson, D
Dube, MP
Hwang, JY
McCutchan, JA
Citation: Rh. Haubrich et al., The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response, AIDS, 13(9), 1999, pp. 1099-1107
Citation: Dn. Forthal, Cytotoxic T lymphocyte precursors in persons with repeated exposure to human immunodeficiency virus, J INFEC DIS, 180(4), 1999, pp. 1406-1406
Authors:
Havlir, DV
Dube, MP
McCutchan, JA
Forthal, DN
Kemper, CA
Dunne, MW
Parenti, DM
Kumar, PN
White, AC
Witt, MD
Nightingale, SD
Sepkowitz, KA
MacGregor, RR
Cheeseman, SH
Citation: Dv. Havlir et al., Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS, CLIN INF D, 27(6), 1998, pp. 1369-1375